Page 21 - Aurobindo Pharma

Aurobindo Pharma gets FDA nod for Alzheimer's, Parkinson's drug

The approved product has an estimated market size of $26.7 million for the 12 months ending January 2016

Aurobindo Pharma gains on USFDA nod for Naproxen Sodium Tablets

The approved product has an estimated market size of US $96 million for 12 months ended January 2016, according to IMS.

Aurobindo Pharma gets final nod for osteoporosis drug

Ibandronate Sodium tablets are used in the treatment and prevention of osteoporosis in postmenopausal women

Aurobindo gets USFDA nod for antidote to pain-killer drug overdose

The product is expected to be launched in the first quarter of the next fiscal

Aurobindo Pharma surges on USFDA nod for anti-HIV tablets

The stock rallied 6% to Rs 649 on USFDA nod for Ritonavir tablets

Aurobindo Pharma gets US FDA nod for anti-HIV tablets

The company's Ritonavir tablets in the strength of 100 mg got the health regulator's tentative approval